Антимикробная активность серамила (синтетического миелопептида) при терапии больных инфекционной экземой
А. В. Дедкова, Л. А. Юсупова · Practical medicine · 2011
Investigation of 137 patients with infectious eczema at the age of 19 to 45 years was conducted. It was established that in patients with infectious eczema Seramil ( synthetic analogue of myelopeptide 3) in contrast to the means of basic therapy showed antimicrobial activity, providing a normalizing effect on parameters of the receptor apparatus of monocytes impaired in infectious eczema: increased the reduced level of CD14 + HLA-DR +, reduced the elevated levels of CD14 + CD25 +, contributed to the significant decrease in the level of gram-positive coccal flora and leads to faster stabilization of the pathologic process.
Cited by 0 works.